Shang K, Huang H, Xu Y, Liu Y, et al. Efficacy and safety analyses of epidermal growth factor receptor tyrosine kinase inhibitors combined with chemotherapy in the treatment of advanced non-small-cell lung cancer with an EGFR/TP53 co-mutation. BMC Cancer 2022;22:1295.
PMID: 36503478